FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet

Kernel’s Brain-Imag­ing Hel­met Approved For Clin­i­cal Tri­al On Patients Using Ket­a­mine (Forbes): The U.S. Food and Drug Admin­is­tra­tion has approved a clin­i­cal tri­al using a neu­roimag­ing hel­met made by Los Ange­les-based Ker­nel to track what hap­pens in the brain when a human takes a psy­che­del­ic dose of ketamine.

Read More

Monitoring neurological signals to detect potential disorders: Key neurotech patent #44

neurological signals

Today we fea­ture an impor­tant Medtron­ic patent. (As men­tioned, we are dis­cussing foun­da­tion­al Per­va­sive Neu­rotech patents, from old­er to new­er by issue date) U.S. Patent No. 8,187,181: Scor­ing of sensed neu­ro­log­i­cal sig­nals for use with a med­ical device sys­tem Assignee(s): Medtron­ic, Inc. Inventor(s): Ivan Oso­rio, Mark G. Frei, Nina M. Graves, Jonathon E. Gif­takis Tech­nol­o­gy Cat­e­go­ry: Neu­ro-mon­i­tor­ing Issue Date:…

Read More